Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorders
ADR ID BADD_A01285
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10013317
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02470Nintedanib--
BADD_D02483Ribociclib--
BADD_D02490Apalutamide0.000667%
BADD_D02503Telotristat ethyl--
BADD_D02504Lorlatinib0.009581%
BADD_D02507Deutetrabenazine--
BADD_D02511Siponimod--
BADD_D02533Bempedoic acid--
BADD_D02537Cabotegravir0.000282%
BADD_D02539Calcium0.000391%
BADD_D02556Ferrous cation--
BADD_D02588Remdesivir0.000565%
BADD_D02592Risdiplam--
BADD_D02603Tucatinib--
BADD_D02615Bilastine--
The 15th Page    First    Pre   15    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target